Information:
Fel:
ID
12654
Beskrivning
Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT00130195
Länk
https://clinicaltrials.gov/show/NCT00130195
Nyckelord
Versioner (1)
- 2015-12-08 2015-12-08 -
Uppladdad den
8 december 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Acute Lymphoblastic Leukemia NCT00130195
Eligibility Acute Lymphoblastic Leukemia NCT00130195
- StudyEvent: Eligibility
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT00130195
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
age, hct
Item
adult subjects with a hct of less than 30 or pediatric subjects less than 25 will be excluded.
boolean
C0001779 (UMLS CUI [1])
C0518014 (UMLS CUI [2])
C0518014 (UMLS CUI [2])
age
Item
children with hcv infection younger than 2 years of age will be excluded.
boolean
C0001779 (UMLS CUI [1])
age
Item
unaffected healthy volunteers who are minors are not eligible for this study.
boolean
C0001779 (UMLS CUI [1])